| Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab M Tanner, M Hollmen, TT Junttila, AI Kapanen, S Tommola, Y Soini, ... Annals of Oncology 16 (2), 273-278, 2005 | 912 | 2005 |
| Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation K Elenius, S Paul, G Allison, J Sun, M Klagsbrun The EMBO journal 16 (6), 1268-1278, 1997 | 424 | 1997 |
| Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer M Tanner, AI Kapanen, T Junttila, O Raheem, S Grenman, J Elo, ... Molecular cancer therapeutics 3 (12), 1585-1592, 2004 | 305 | 2004 |
| Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck … K Erjala, M Sundvall, TT Junttila, N Zhang, M Savisalo, P Mali, J Kulmala, ... Clinical Cancer Research 12 (13), 4103-4111, 2006 | 302 | 2006 |
| Induced expression of syndecan in healing wounds. K Elenius, S Vainio, M Laato, M Salmivirta, I Thesleff, M Jalkanen The Journal of cell biology 114 (3), 585-595, 1991 | 302 | 1991 |
| High frequency of BRAF V600E mutations in ameloblastoma KJ Kurppa, J Catón, PR Morgan, A Ristimäki, B Ruhin, J Kellokoski, ... The Journal of pathology 232 (5), 492-498, 2014 | 281 | 2014 |
| A novel juxtamembrane domain isoform of HER4/ErbB4: isoform-specific tissue distribution and differential processing in response to phorbol ester K Elenius, G Corfas, S Paul, CJ Choi, C Rio, GD Plowman, M Klagsbrun Journal of Biological Chemistry 272 (42), 26761-26768, 1997 | 281 | 1997 |
| Syndecan from embryonic tooth mesenchyme binds tenascin. M Salmivirta, K Elenius, S Vainio, U Hofer, R Chiquet-Ehrismann, ... Journal of Biological Chemistry 266 (12), 7733-7739, 1991 | 256 | 1991 |
| Cleavable ErbB4 isoform in estrogen receptor–regulated growth of breast cancer cells TT Junttila, M Sundvall, M Lundin, J Lundin, M Tanner, P Härkönen, ... Cancer research 65 (4), 1384-1393, 2005 | 222 | 2005 |
| Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase K Elenius, CJ Choi, S Paul, E Santiestevan, E Nishi, M Klagsbrun Oncogene 18 (16), 2607-2615, 1999 | 212 | 1999 |
| ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease RJ Gilbertson, L Bentley, R Hernan, TT Junttila, AJ Frank, H Haapasalo, ... Clinical Cancer Research 8 (10), 3054-3064, 2002 | 201 | 2002 |
| A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis V Kainulainen, M Sundvall, JA Määttä, E Santiestevan, M Klagsbrun, ... Journal of Biological Chemistry 275 (12), 8641-8649, 2000 | 196 | 2000 |
| Function of the syndecans-a family of cell surface proteoglycans K Elenius, M Jalkanen Journal of Cell Science 107 (11), 2975-2982, 1994 | 196 | 1994 |
| The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 DJ Riese, ED Kim, K Elenius, S Buckley, M Klagsbrun, GD Plowman, ... Journal of Biological chemistry 271 (33), 20047-20052, 1996 | 195 | 1996 |
| Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization J Korhonen, J Partanen, E Armstrong, A Vaahtokari, K Elenius, ... | 183 | 1992 |
| Growth factors induce 3T3 cells to express bFGF-binding syndecan. K Elenius, A Määttä, M Salmivirta, M Jalkanen Journal of Biological Chemistry 267 (9), 6435-6441, 1992 | 179 | 1992 |
| Binding of human syndecan to extracellular matrix proteins. K Elenius, M Salmivirta, P Inki, M Mali, M Jalkanen Journal of Biological Chemistry 265 (29), 17837-17843, 1990 | 179 | 1990 |
| Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst … BC Paria, K Elenius, M Klagsbrun, SK Dey Development 126 (9), 1997-2005, 1999 | 171 | 1999 |
| Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth JA Määttä, M Sundvall, TT Junttila, L Peri, VJO Laine, J Isola, ... Molecular biology of the cell 17 (1), 67-79, 2006 | 169 | 2006 |
| Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants TT Junttila, M Sundvall, JA Määttä, K Elenius Trends in cardiovascular medicine 10 (7), 304-310, 2000 | 169 | 2000 |
